Adimmune announces financail statements of 2022 second quarter.
· Issued by Adimmune Corporation
Close
Today's Information
Provided by: ADIMMUNE CORPORATION
SEQ_NO
4
Date of announcement
2022/08/12
Time of announcement
14:28:21
Subject
Adimmune announces financail statements of
2022 second quarter.
Date of events
2022/08/12
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/08/12
2.Date of approval by the audit committee:N/A
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):579,733
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):96,209
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):-288,250
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):-267,949
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):-267,949
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):-189,308
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):-0.44
11.Total assets end of the period (thousand NTD):8,843,856
12.Total liabilities end of the period
(thousand NTD):2,685,904
13.Equity attributable to owners of parent end of the
period (thousand NTD):5,816,773
14.Any other matters that need to be specified:N/A
